Mezigdomide is effective alone and in combination with menin inhibition in preclinical models of KMT2A-r and NPM1c AML
Article in Blood (April 2024)
The most recent citing publications are shown below. View all 208 publications that cite this research output on Dimensions.
Article in Blood (April 2024)
Preprint in bioRxiv (December 2023)
Article in Nature Communications (November 2023)